Tcg Crossover Management, LLC Entrada Therapeutics, Inc. Transaction History
Tcg Crossover Management, LLC
- $668 Million
- Q2 2024
A detailed history of Tcg Crossover Management, LLC transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Tcg Crossover Management, LLC holds 584,955 shares of TRDA stock, worth $10.1 Million. This represents 1.25% of its overall portfolio holdings.
Number of Shares
584,955
Previous 584,955
-0.0%
Holding current value
$10.1 Million
Previous $8.29 Million
0.57%
% of portfolio
1.25%
Previous 0.87%
Shares
3 transactions
Others Institutions Holding TRDA
# of Institutions
87Shares Held
27.8MCall Options Held
100Put Options Held
0-
Baker Bros. Advisors LP New York, NY4.87MShares$83.8 Million0.92% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.43MShares$76.3 Million34.63% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.41MShares$76 Million29.39% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.13MShares$54 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.69MShares$29.2 Million0.0% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $540M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...